The promise of the abscopal effect and the future of trials combining immunotherapy and radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 95, Issue 4, 2016, Pages 1254-1256

  Johnson, C Bryce ^a   Jagsi, Reshma ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PROGRAMMED DEATH 1 RECEPTOR INHIBITOR; PROTEIN INHIBITOR; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 AGONIST; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL (TOPIC); HUMAN; MULTIPLE CANCER; NOTE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; VACCINATION; FORECASTING; IMMUNOTHERAPY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PROCEDURES; RADIOTHERAPY;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FORECASTING; HUMANS; IMMUNOTHERAPY; NEOPLASMS; RADIOTHERAPY; RESEARCH DESIGN; VACCINATION;

EID: 84975221157     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.02.067     Document Type: Article

References (5)

1. S. Demaria, E.B. Golden, and S.C. Formenti Role of local radiation therapy in cancer immunotherapy JAMA Oncol 1 2015 1325 1332
2. A.B. Sharabi, M. Lim, T.L. DeWeese, and et al. Radiation and checkpoint blockade immunotherapy: Radiosensitisation and potential mechanisms of synergy Lancet Oncol 16 2015 e498 e509
3. C. Vanpouille-Box, K.A. Pilones, E. Wennerberg, and et al. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment Vaccine 33 2015 7415 7422
4. K. Reynders, T. Illidge, S. Siva, and et al. The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant Cancer Treat Rev 41 2015 503 510
5. F. Klug, H. Prakash, P.E. Huber, and et al. Low-dose irradiation programs macrophage differentiation to an iNOS(+)/M1 phenotype that orchestrates effective T cell immunotherapy Cancer Cell 24 2013 589 602